Medical Sysmex Reagents and Microbiological Media Plates
ID: DLATSP25SS0002Type: Sources Sought
Overview

Buyer

DEPT OF DEFENSEDEFENSE LOGISTICS AGENCYDLA TROOP SUPPORT INDO-PACIFICJBPHH, HI, 96860-3520, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)
Timeline
    Description

    The Defense Logistics Agency (DLA) Troop Support Pacific is conducting market research to identify local sources for the procurement and delivery of medical laboratory reagents and microbiological media plates in support of the United States Naval Hospital (USNH) located in Okinawa, Japan. This sources sought announcement aims to gather information on potential suppliers capable of fulfilling a requirement for Class VIII medical supplies, which are critical for laboratory diagnostics and healthcare operations. The anticipated contract will be a Firm-Fixed Price Indefinite Delivery, Indefinite Quantity type, with a base period of 12 months and one option period, estimated under $250,000, inclusive of shipping and delivery. Interested parties must submit their responses by 12:00 pm JST on October 13, 2024, to the designated contacts, Mamiko Jackson and Arlene Renner, via email.

    Point(s) of Contact
    Files
    Title
    Posted
    The document presents an Independent Government Estimate (IGE) for medical supplies required in FY 2026, specifically focusing on BD Media Plates and Sysmex Reagents. The estimate details various laboratory items categorized under medical use, including coagulation levels, buffers, diluents, reagents, and agar plates used in diagnostics. Each line item comprises the item description, unit of measure, unit of issue, quantity, and extended price, though the prices are not specified in the excerpt. Key items listed include CI-TROL Coagulation levels, D-Dimer standards, and a variety of agar media crucial for microbiological testing. The structure highlights the required quantities for efficient laboratory function and testing reliability in healthcare settings. This IGE serves the purpose of guiding procurement processes in alignment with government regulations for federal grants and RFPs, ensuring that the necessary medical supplies are available for future operations. The detailed inventory facilitates transparency in government spending and resource allocation in medical facilities, reinforcing the importance of maintaining stock for adequate healthcare services.
    Lifecycle
    Title
    Type
    Similar Opportunities
    Specimen Container Peel Pack
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is seeking vendors for the Qualified Suppliers Listing (QSL) for Specimen Container Peel Pack products intended for use in Military Treatment Facilities and operational assemblages. Vendors must possess or apply for a Distribution and Pricing Agreement (DAPA) number, maintain active registration with the System for Award Management (SAM), and have agreements with DoD Medical/Surgical Prime Vendors such as Cardinal Health and Owens & Minor. This initiative is crucial for standardizing medical supplies within the Military Health System, ensuring compliance with quality standards and regulations, including the Trade Agreements Act (TAA). Interested vendors should submit their QSL Package Worksheet and supporting documentation by August 1, 2024, and can direct inquiries to Cornelius Brother at cornelius.l.brothers.ctr@health.mil or Moises Soto at moises.soto1.ctr@health.mil.
    Up to 60 months Lease of 7 MFDs to be located in Japan
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA) Data Management Services, is seeking qualified contractors for a 60-month lease of seven small-format color and black & white reproduction devices to be located in Kadena, Okinawa, Japan. The procurement includes comprehensive services such as delivery, installation, maintenance, consumable supplies, IT security support, and operator training, with a focus on maintaining a minimum of 90% monthly uptime and compliance with energy standards. This initiative is crucial for ensuring efficient and secure operations within the DLA's facilities in Japan. Interested parties must submit their information, including business name and SAM UEI number, to the primary contact, Patrick D'Arcy, at patrick.d'arcy@dla.mil by January 6, 2025, at 12:00 PM EST.
    Oncotype DX Genomic Testing for Tripler Army Medical Center, Hawaii
    Active
    Dept Of Defense
    The Department of Defense, through the Medical Readiness Contracting Office - Pacific, is seeking qualified vendors to provide Oncotype DX Genomic Testing Services for the Department of Pathology at Tripler Army Medical Center in Hawaii. This procurement aims to acquire clinically-validated molecular diagnostics that offer individualized information regarding therapy responses and the likelihood of disease recurrence. The Government intends to award a Firm Fixed-Price contract, with responses due by December 30, 2024, at 10:00 AM Hawaii Standard Time. Interested organizations must submit their capabilities and qualifications to Leslie Takayama via email at leslie.m.takayama.civ@health.mil, ensuring they are registered in the System for Award Management (SAM) with the appropriate NAICS code 621511.
    Microbiology Lab CPRR - Keesler AFB, MS
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency, is seeking proposals for the procurement of microbiology laboratory equipment at Keesler Air Force Base in Mississippi. The requirement includes one automated microbial identification system and one automated microbial detection system, along with all necessary equipment, reagents, and maintenance services, to enhance the laboratory's capabilities in microbial testing. This initiative is crucial for improving healthcare services by ensuring accurate and timely microbiology testing, which is essential for patient care. Interested vendors must submit their proposals by January 24, 2025, and can contact Carolynn Benn at carolynn.j.benn.civ@health.mil or David Erpelding at david.k.erpelding.civ@health.mil for further information.
    Analytical Sample Processing Systems
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency (DHA) and the Army Medical Research Acquisition Activity, is seeking information regarding Analytical Sample Processing Systems for the Walter Reed Army Institute of Research (WRAIR). The procurement involves leasing, installation, and validation of pre- and post-analytical specimen processing instrumentation systems, along with preventative and emergency maintenance and necessary consumables. These systems are crucial for ensuring sample integrity and efficient laboratory operations, with a focus on modular design and automated processes. Interested vendors should submit detailed capability statements by December 23, 2024, as the estimated performance period for the systems is from August 2025 to August 2030. For further inquiries, potential respondents can contact Joshua Dean at joshua.r.dean2.civ@health.mil or Jennifer Hayden at jennifer.e.hayden.civ@health.mil.
    RT-PCR Molecular Testing for Transplant, Respiratory, and Sexual Health Infections Department of Pathology and Area Laboratory Services (DPALS)
    Active
    Dept Of Defense
    The Department of Defense, specifically the Department of the Army, is seeking sources for RT-PCR molecular testing solutions to support the Brooke Army Medical Center’s Department of Pathology and Area Laboratory Services in Fort Cavazos, Texas. The procurement aims to acquire a random-access multiplex testing platform that utilizes FDA-approved reagents and analyzers for various infectious disease tests, including Hepatitis B and C, HIV, and respiratory viruses, thereby enhancing laboratory capabilities and workflow efficiency. This initiative is critical for maintaining high testing standards for military personnel, with a contract period anticipated from October 2025 to September 2026, including three potential extension years. Interested vendors are encouraged to submit capabilities statements by December 30, 2024, and may contact Colleen Rye or Salameya Paulouskaya for further information.
    Vaginal Specula Disposable
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is preparing to establish a Qualified Suppliers Listing (QSL) for Disposable Vaginal Specula. This initiative aims to solicit information and products for evaluation, focusing on single-use, sterile and non-sterile Pederson style vaginal specula in various sizes, which will be utilized in outpatient OB/GYN, emergency department, or urgent care settings, excluding surgical procedures. Interested vendors must have or be in the process of obtaining a Distribution and Pricing Agreement (DAPA) and ensure compliance with the Trade Agreements Act (TAA), with the QSL Announcement expected to be released on or about February 2, 2025. For further inquiries, vendors can contact Tara J. Perrien, Contracting Officer, at tara.perrien@dla.mil or the MMESO Enterprise Wide Standardization at dha.detrick.med-log.mbx.mmeso@mail.mil.
    65--DANTROLENE SODIUM F
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA Troop Support), is seeking quotes for the procurement of Dantrolene Sodium F, a critical medical supply. The solicitation includes multiple line items, each requiring a quantity of three units to be delivered to the W05J Medical Maintenance Operations Division at Tobyhanna, with a delivery timeline of five days after order. Dantrolene Sodium is essential for treating malignant hyperthermia and is vital for patient safety in medical settings. Interested vendors must submit their quotes electronically, and any inquiries regarding the solicitation should be directed to the buyer via email at DibbsBSM@dla.mil.
    Joint Operational Medicine Medical Logistics Capabilities
    Active
    Dept Of Defense
    The Defense Health Agency (DHA) is seeking information on innovative Operational Medicine (OpMed) Medical Logistics (MEDLOG) solutions for the Joint Operational Medicine Information System (JOMIS). The objective is to identify potential solutions that ensure joint interoperability and meet baseline requirements for survivability, patient safety, and quality of care in various operational environments, particularly under Denied, Disrupted, Intermittent, and Low-Bandwidth (DDIL) conditions. This initiative is crucial for enhancing military medical logistics capabilities, as the current Defense Medical Logistics Standard Support (DMLSS) system is set to be decommissioned by February 2028. Interested vendors must submit their responses by December 18, 2025, and can direct inquiries to Elizabeth M. Ruckwardt at elizabeth.m.ruckwardt.civ@health.mil.
    Dimethyl Fumarate DR Presolicitation
    Active
    Dept Of Defense
    The Defense Logistics Agency (DLA) is planning to issue a solicitation for a national requirements contract for Dimethyl Fumarate DR capsules, specifically 120MG capsules in 14 count bottles and 240MG capsules in 60 count bottles. This procurement aims to establish a reliable national supply source for these pharmaceutical products, which are essential for Department of Defense (DoD) customers through the DLA prime vendor program. The contract will be a firm-fixed price, requirements type contract with a one-year base period and four one-year options, emphasizing compliance with federal regulations and efficient distribution of pharmaceuticals for military healthcare. Interested parties should contact Kevin Rafferty at kevin.rafferty@dla.mil or 215-737-0907 for further inquiries, and the projected solicitation date is February 2021, with an amendment extending the offer submission deadline to October 14, 2021, at 3:00 PM EST.